Correlation Between Centessa Pharmaceuticals and CopAur Minerals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and CopAur Minerals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and CopAur Minerals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and CopAur Minerals, you can compare the effects of market volatilities on Centessa Pharmaceuticals and CopAur Minerals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of CopAur Minerals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and CopAur Minerals.

Diversification Opportunities for Centessa Pharmaceuticals and CopAur Minerals

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Centessa and CopAur is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and CopAur Minerals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CopAur Minerals and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with CopAur Minerals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CopAur Minerals has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and CopAur Minerals go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and CopAur Minerals

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.4 times more return on investment than CopAur Minerals. However, Centessa Pharmaceuticals PLC is 2.5 times less risky than CopAur Minerals. It trades about 0.02 of its potential returns per unit of risk. CopAur Minerals is currently generating about -0.04 per unit of risk. If you would invest  1,628  in Centessa Pharmaceuticals PLC on September 17, 2024 and sell it today you would earn a total of  29.00  from holding Centessa Pharmaceuticals PLC or generate 1.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  CopAur Minerals

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
CopAur Minerals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CopAur Minerals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Centessa Pharmaceuticals and CopAur Minerals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and CopAur Minerals

The main advantage of trading using opposite Centessa Pharmaceuticals and CopAur Minerals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, CopAur Minerals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CopAur Minerals will offset losses from the drop in CopAur Minerals' long position.
The idea behind Centessa Pharmaceuticals PLC and CopAur Minerals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.